Workflow
The partial demerger of Lassila & Tikanoja plc has been registered – New Lassila & Tikanoja to be listed on Nasdaq Helsinki
Globenewswire· 2025-12-31 12:00
Lassila & Tikanoja PlcStock exchange release31 December 2025 at 2.00 pm The partial demerger of Lassila & Tikanoja plc has been registered – New Lassila & Tikanoja to be listed on Nasdaq Helsinki The completion of the partial demerger (the “Demerger”) of Lassila & Tikanoja plc (“Lassila & Tikanoja” or the “Demerging Company”) has today on 31 December 2025 been registered with the Finnish Trade Register. Lassila & Tikanoja announced on 7 August 2025 the approval of the demerger plan concerning the Demerger ( ...
Labrador Gold Announces Acquisition of Subscription Receipts of Northern Shield
Globenewswire· 2025-12-31 12:00
TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce that, further to its press release of December 8, 2025 (the “COB Press Release”), it has acquired 16,666,667 Subscription Receipts (the “Northern Shield Financing”) of Northern Shield Resources Inc. (“Northern Shield”) at $0.06 per Subscription Receipt for an investment of $1,000,000.02 (the “Initial Investment Funds”) pursuant to a subscription agreement ...
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission
Globenewswire· 2025-12-31 11:55
Core Viewpoint - Axsome Therapeutics is on track to submit a New Drug Application (NDA) for AXS-12, a treatment for cataplexy in narcolepsy, by January 2026, following positive feedback from the FDA regarding the regulatory data package [2][3][4]. Company Overview - Axsome Therapeutics is a biopharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, with a portfolio that includes FDA-approved therapies for major depressive disorder and excessive daytime sleepiness associated with narcolepsy [8]. Product Details - AXS-12 (reboxetine) is a selective norepinephrine reuptake inhibitor and cortical dopamine modulator, aimed at treating narcolepsy by promoting wakefulness and enhancing cognition [7]. - AXS-12 has received Orphan Drug Designation from the FDA, which may provide seven years of marketing exclusivity upon approval and a waiver of application user fees [5]. Clinical Development - The clinical development program for AXS-12 includes three controlled efficacy trials and a completed long-term safety trial, indicating a robust approach to validating the drug's effectiveness and safety [4]. Market Context - Narcolepsy is a serious neurological condition affecting the sleep-wake cycle, characterized by excessive daytime sleepiness and cataplexy, which impacts cognitive and social functioning and is associated with a higher mortality rate [6].
Magna Mining Files Technical Report for the Mineral Resource Estimate on the Levack Mine Property in Sudbury 
Globenewswire· 2025-12-31 11:45
Core Viewpoint - Magna Mining Inc. has filed an independent technical report regarding the mineral resource estimate for the Levack Mine, enhancing transparency and compliance with industry standards [1][2]. Group 1: Technical Report Details - The technical report is prepared in accordance with National Instrument 43-101, ensuring adherence to standards for mineral project disclosures [2]. - The report is dated December 31, 2025, with an effective date of August 31, 2025, and was prepared by Orix Geoscience Inc. [2]. Group 2: Company Overview - Magna Mining Inc. operates in the Sudbury mining district of Ontario, Canada, focusing on copper, nickel, and platinum group metals (PGM) [4]. - The primary asset of the company is the McCreedy West Mine, which is currently in production, alongside a portfolio of other prospective properties including Levack, Crean Hill, Podolsky, and Shakespeare [4]. - The company aims to unlock long-term shareholder value through ongoing production, exploration potential, and near-term development opportunities [5].
Brown & Brown, Inc. announces 2025 fourth-quarter earnings release and conference call dates
Globenewswire· 2025-12-31 11:45
Core Viewpoint - Brown & Brown, Inc. is set to release its fourth-quarter earnings for 2025 on January 26, 2026, with an investor update conference call scheduled for January 27, 2026 [1] Company Overview - Brown & Brown, Inc. is a leading insurance brokerage firm established in 1939, providing comprehensive and customized insurance solutions [2] - The company operates over 700 locations globally and employs more than 23,000 professionals [2] - Brown & Brown is committed to delivering scalable and innovative strategies to support customer growth [2]
Strawberry Fields REIT Inc. (NYSE American: STRW) CEO Highlights Discipline, Scale, and Steady Returns at NobleCon21
Globenewswire· 2025-12-31 11:30
Core Insights - Strawberry Fields REIT focuses on disciplined acquisition and long-term stability in healthcare-related properties, particularly skilled nursing facilities [1][9] - The company has significantly expanded its portfolio since 2015, now holding interests in 142 facilities with over 15,500 licensed beds, representing about 1% of U.S. nursing home capacity [3][9] - The U.S. elderly care market is projected to grow from $49.29 billion in 2024 to $98.19 billion by 2032, indicating a favorable environment for the company's growth strategy [3] Acquisition Strategy - The company employs a conservative acquisition strategy, reviewing approximately 300 potential acquisitions annually and closing five to ten properties each year [4] - Strawberry Fields utilizes master leases to group properties, reducing risk and ensuring consistent rent collection, which has been at 100% for seven to eight consecutive years [5][9] Financial Performance - For Q3 2025, the company reported rental income of $39.7 million, an increase of $6.6 million from the previous year, and Funds From Operations (FFO) rose to $20.7 million [10][11] - The company maintains a conservative payout ratio of approximately 47%, allowing for retained cash flow to support acquisitions and long-term growth [11][12] Portfolio and Market Position - Strawberry Fields' portfolio includes 142 healthcare facilities across ten states, with a diverse tenant base that has expanded from initial concentrations in two states [8][14] - The company reports approximately $1.1 billion in assets and a market capitalization of about $750 million, with plans to secure a traditional unsecured line of credit to enhance liquidity [12]
Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend Probe Gold Shareholders Vote FOR the Proposed Plan of Arrangement with Fresnillo
Globenewswire· 2025-12-31 11:30
Core Viewpoint - Probe Gold Inc. is set to undergo a significant transaction where Fresnillo plc will acquire all outstanding common shares of Probe for C$3.65 per share, totaling approximately C$780 million, with independent proxy advisory firms recommending shareholders vote in favor of the arrangement [1][2][4]. Transaction Details - The cash consideration of C$3.65 per share represents a 39% premium over the closing price on October 30, 2025, and a 26% premium based on the volume-weighted average price over the preceding 20 trading days [2]. - The transaction is expected to close in Q1 2026, pending the approval of the Arrangement Resolution and other conditions outlined in the arrangement agreement [3]. Advisory Recommendations - Institutional Shareholder Services Inc. (ISS) stated that the arrangement is strategically sound, providing immediate value and certainty to shareholders, with a positive market reaction [4]. - Glass Lewis concluded that the transaction offers reasonable financial terms, representing an attractive opportunity for shareholders to realize fair value and full liquidity [4]. Board of Directors' Position - The Board of Directors unanimously recommends that shareholders vote in favor of the Arrangement Resolution, deeming the transaction to be in the best interests of the Company [5]. Shareholder Meeting Information - A special meeting for shareholders to vote on the Arrangement Resolution is scheduled for January 13, 2026, at 11:00 a.m. Toronto time [6]. - Shareholders must vote by proxy by 11:00 a.m. on January 9, 2026, to participate in the meeting [7]. Voting Support Agreements - Directors and officers of Probe, along with Eldorado Gold Corporation, holding approximately 12% of the shares, have entered into voting support agreements to vote in favor of the transaction [8]. Company Overview - Probe Gold Inc. is a Canadian gold exploration company focused on acquiring and developing high-quality gold properties, including the multimillion-ounce Novador Gold Project in Québec [10].
Liberty Gold Provides Year-End Update on Goldstrike and Critical Minerals Assets
Globenewswire· 2025-12-31 11:00
VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to provide a year-end update on the Company’s ongoing activities designed to surface long-term value from the Goldstrike Oxide Gold Project (“Goldstrike”), Antimony Ridge discovery (“Antimony Ridge”) and the recently acquired Gage Critical Metals Project (“Gage”) in southwest Utah. Jon Gilligan, President & CEO of Liberty Gold, commented, “Earlier this year, ...
Smart Share Global Limited Announces Shareholders’ Approval of Merger Agreement
Globenewswire· 2025-12-31 11:00
SHANGHAI, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that at an extraordinary general meeting of shareholders (the “EGM”) held today, the Company’s shareholders voted in favor of the proposal to authorize and approve the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated August 1, 2025, by and among the Company, Mobile Charging G ...
The Weaver Launches its "Seven-Country Wellness Village Project" from Taiwan
Globenewswire· 2025-12-31 09:55
Core Concept - The article discusses the launch of the "Seven Countries Wellness Village Project" aimed at addressing the retirement housing needs of overseas Chinese, emphasizing health, dignity, and a sense of belonging [2][4]. Group 1: Project Overview - The "Seven Countries Wellness Village Project" is initiated by The Weaver to create wellness villages in seven countries, focusing on health management, smart healthcare, and community living tailored for overseas Chinese [6]. - The project aims to provide a living community that offers long-term care and maintains social connections, addressing the modern retirement issue beyond just financial aspects [5][6]. Group 2: Charity Initiative - A charity book donation campaign was launched by Chairman CHIO Hsiaochuh and various celebrities to promote the project, with books covering topics like financial planning and health management [2][4]. - The book giveaway event started in Taiwan, symbolizing the beginning of a global promotion strategy [4]. Group 3: Vision and Future Plans - CHIO Hsiaochuh expressed the vision that there should be a place for all overseas Chinese to return to, with Taiwan as the starting point for this initiative [7]. - The Weaver plans to advance the project through forums, briefings, collaborations, and the construction of demonstration wellness villages to establish a sustainable retirement living model for Chinese people worldwide [7].